Atlas Trials

Assess the Long-term Effectiveness and Safety of Amevive (Alefacept) in Subjects With Moderate to Severe Chronic Plaque Psoriasis

Clinical trial NCT00795353 · TERMINATED

Trial details

NCT number
NCT00795353
Sponsor
Astellas Pharma Inc
Status
TERMINATED
Study type
OBSERVATIONAL
Chronic Plaque Psoriasis
Start date
2008-07-01
Primary completion
2011-01-01
Enrollment
64

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.